絞り込み

16763

広告

Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.

著者 Brada M , Viviers L , Abson C , Hines F , Britton J , Ashley S , Sardell S , Traish D , Gonsalves A , Wilkins P , Westbury C
Ann Oncol.2003 Dec ; 14(12):1715-21.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Neuro-Oncology Unit, The Royal Marsden NHS Trust, and Academic Unit of Radiotherapy and Oncology, The Institute of Cancer Research, Sutton, Surrey, UK. frada@icr.ac.uk

スターを付ける スターを付ける     (23view , 0users)

Full Text Sources

Medical

Miscellaneous

The aim of this study was to assess the efficacy of temozolomide in patients with World Health Organisation (WHO) grade II gliomas treated with surgery alone using imaging and clinical criteria.
PMID: 14630674 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード